Tag: key opinion leaders
Branding DiseasesâHow Drug Companies Market Psychiatric Conditions: An Interview with Ray...
MIAâs Ayurdhi Dhar interviews Ray Moynihan about the marketing of disorders, broadening of diagnoses, and harmful treatments.
Jon JureidiniâEvidence-Based Medicine in a Post-Truth World
In this interview, Jon Jureidini talks about the issues with evidence-based medicine and describes what led to the debasement of a system originally conceived to challenge extravagant claims and poor science.
New Study Challenges Impartiality of Peer Review
New research shows that more connected and well-known researchers are more likely to be published, even when they receive negative reviews.
Interview: Researchers Deconstruct Ghostwritten Industry Trial for Antidepressant
Researchers, Jon Jureidini, Jay Amsterdam and Leemon McHenry, have taken a closer look at the data from a randomized control trial of citalopram (Celexa) that was ghostwritten and then used by the manufacturers to support claims of the drugâs efficacy and safety in the treatment of child and adolescent depression. To get the background on this story, we connected with Dr. Leemon McHenry, an investigator in this study and a lecturer in philosophy at California State University, Northridge.
